Top 3 reasons your 510(k) submission was rejected – Part I
Ex-SurModics CEO Ankeny starts as new Minnetronix CFO | Personnel Moves
New Minnetronix CFO started yesterday
The new CFO of Minnetronix, Phil Ankeny, joined the company today. Ankeny moved over to Minnetronix from SurModics Inc., where he served as interim CEO and CFO. His background is in venture capital, IT startups and investment banking.
Aptiv Solutions Reaches First Milestone in Delivering New Platform for Model-Based Dose-Finding Trials (ADDPLAN® DF)
RESTON, Va.–(BUSINESS WIRE)–Aptiv Solutions, a biopharmaceutical and medical device development services company, and the leader in adaptive clinical trial design, simulation and execution, announces the completion of a key milestone in the development of a new platform for phase Ib and II adaptive design clinical trials.
Aptiv opens new office in North Carolina
Reston, Va.-based Aptiv Solutions opened new office in North Carolina, where it plans to hire more staff and combine Aptiv Solutions and its subsidiary Trio Clinical Resourcing under 1 roof.
Aptiv offers biopharmaceutical and medtech development services, including clinical trial design and execution as well as medical device consulting and trial execution.
Sign up to get our free newsletters delivered right to your inbox.
[sead]
Former Minntech CEO Malkin back on the job | Personnel Moves
Roy Malkin, the former CEO of Minntech Corp. who was seriously injured last spring in a plane crash, has been back with the company on a limited basis since September, according to a regulatory filing.
Malkin’s private single-jet plane crashed in early June in Crystal, Minn., as the plane was attempting to take off.
NuVasive closes Impulse Monitoring deal | Acquisitions Roundup
NuVasive (NSDQ:NUVA) closed its $80 million pickup of Impulse Monitoring Inc. last week, according to a filing with the federal Securities & Exchange Commission.
The deal, which closed Oct. 7, saw IMI’s shareholders receive nearly $40.5 million in cash and more than 2.3 million shares of NuVasive common stock with an aggregate value of about $40.5 million (per NUVA’s Oct. 6 closing share price of $17.32).
MDT’s new CEO, MDT’s former CEO, devices to save Steve Jobs, Beckman Coulter’s warnings, KCI’s new suitor, Aptiv’s grab for MDCI and regulatory science made headlines this week. | MassDevice.com +7
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
Aptiv widens footprint in med-tech regulation with MDCI buyout | Acquisitions roundup
Life sciences consulting company Aptiv Solutions announced that it acquired Medical Device Consultants Inc., broadening its reach in medical device regulation and strategy.
North Attleboro, Mass.-based regulatory consulting and clinical research organization MDCI has been around since 1980, offering regulatory and clinical services to the med-tech sector.
Clinical Research firm Trio rebrands, changes strategy after merger
The North Carolina CRO that launched as Trio Clinical Research is moving forward with a new name and a different strategy.
Trio changed its official name to Trio Clinical Resourcing, a change that reflects the Raleigh, N.C.-based CRO’s focus on providing recruiting and staffing services to biotechnology, pharmaceutical and medical device companies, according to Trio.
